Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

B cells or T cells in TB: a continuing conundrum.

Maeurer M, Rao M, Zumla A.

Lancet Respir Med. 2018 Apr;6(4):237-238. doi: 10.1016/S2213-2600(18)30080-8. No abstract available.

PMID:
29595500
2.

Low number of peripheral blood B lymphocytes in patients with pulmonary tuberculosis.

Hernandez J, Velazquez C, Valenzuela O, Robles-Zepeda R, Ruiz-Bustos E, Navarro M, Garibay-Escobar A.

Immunol Invest. 2010 Jan;39(3):197-205. doi: 10.3109/08820130903586346.

PMID:
20380518
3.

Role of B Cells in Mucosal Vaccine-Induced Protective CD8+ T Cell Immunity against Pulmonary Tuberculosis.

Khera AK, Afkhami S, Lai R, Jeyanathan M, Zganiacz A, Mandur T, Hammill J, Damjanovic D, Xing Z.

J Immunol. 2015 Sep 15;195(6):2900-7. doi: 10.4049/jimmunol.1500981. Epub 2015 Aug 12.

4.

Purification, biochemical characterization and immunogenicity of SA5K, a secretion antigen of Mycobacterium tuberculosis.

Batoni G, Bottai D, Esin S, Florio W, Pardini M, Maisetta G, Freer G, Senesi S, Campa M.

Scand J Immunol. 2002 Jul;56(1):43-51.

5.

CD4+ T cells contain early extrapulmonary tuberculosis (TB) dissemination and rapid TB progression and sustain multieffector functions of CD8+ T and CD3- lymphocytes: mechanisms of CD4+ T cell immunity.

Yao S, Huang D, Chen CY, Halliday L, Wang RC, Chen ZW.

J Immunol. 2014 Mar 1;192(5):2120-32. doi: 10.4049/jimmunol.1301373. Epub 2014 Jan 31.

6.

Pulmonary tuberculosis patients with a vitamin D deficiency demonstrate low local expression of the antimicrobial peptide LL-37 but enhanced FoxP3+ regulatory T cells and IgG-secreting cells.

Rahman S, Rehn A, Rahman J, Andersson J, Svensson M, Brighenti S.

Clin Immunol. 2015 Feb;156(2):85-97. doi: 10.1016/j.clim.2014.12.003. Epub 2014 Dec 12.

7.

Airway luminal T cells: a newcomer on the stage of TB vaccination strategies.

Jeyanathan M, Heriazon A, Xing Z.

Trends Immunol. 2010 Jul;31(7):247-52. doi: 10.1016/j.it.2010.05.002. Epub 2010 Jun 11.

PMID:
20542470
8.
9.

T and B lymphocytes in patients with pulmonary tuberculosis.

Zwoliński J, Wieczorek Z, Skibiński G.

Arch Immunol Ther Exp (Warsz). 1976;24(5):689-95.

PMID:
1087146
10.

Feasibility of the T-SPOT.TB assay for the immunodiagnosis of smear-positive pulmonary tuberculosis using induced sputum.

Dilektasli AG, Erdem E, Durukan E, Eyüboğlu FO.

Int J Tuberc Lung Dis. 2010 Sep;14(9):1205-8.

PMID:
20819270
11.

Inhibiting the programmed death 1 pathway rescues Mycobacterium tuberculosis-specific interferon γ-producing T cells from apoptosis in patients with pulmonary tuberculosis.

Singh A, Mohan A, Dey AB, Mitra DK.

J Infect Dis. 2013 Aug 15;208(4):603-15. doi: 10.1093/infdis/jit206. Epub 2013 May 9.

PMID:
23661793
12.

Association of immunophenotypic characterization of peripheral lymphocytes with different clinical phenotypes of tuberculosis in Chinese Han children.

Xiao J, Sun L, Wu XR, Miao Q, Jiao WW, Shen C, Shen D, Feng WX, Liu F, Shen AD.

Chin Med J (Engl). 2012 Jan;125(2):275-80.

PMID:
22340559
13.

Evaluation of profile and functionality of memory T cells in pulmonary tuberculosis.

Tonaco MM, Moreira JD, Nunes FFC, Loures CMG, Souza LR, Martins JM, Silva HR, Porto AHR, Toledo VPCP, Miranda SS, Guimarães TMPD.

Immunol Lett. 2017 Dec;192:52-60. doi: 10.1016/j.imlet.2017.10.014. Epub 2017 Oct 26.

PMID:
29106984
14.

Understanding delayed T-cell priming, lung recruitment, and airway luminal T-cell responses in host defense against pulmonary tuberculosis.

Shaler CR, Horvath C, Lai R, Xing Z.

Clin Dev Immunol. 2012;2012:628293. doi: 10.1155/2012/628293. Epub 2012 Apr 1. Review.

15.

Heparin-binding, hemagglutinin-specific IFN-gamma synthesis at the site of infection during active tuberculosis in humans.

Place S, Verscheure V, de San N, Hougardy JM, Schepers K, Dirix V, Dediste A, Michel O, Drowart A, Allard SD, Doherty TM, Lecher S, Locht C, Mascart F.

Am J Respir Crit Care Med. 2010 Sep 15;182(6):848-54. doi: 10.1164/rccm.201001-0083OC. Epub 2010 May 27.

PMID:
20508213
16.

Interleukin 17-producing gamma delta T cells increased in patients with active pulmonary tuberculosis.

Peng MY, Wang ZH, Yao CY, Jiang LN, Jin QL, Wang J, Li BQ.

Cell Mol Immunol. 2008 Jun;5(3):203-8. doi: 10.1038/cmi.2008.25.

17.

Peripheral blood mononuclear cells immunophenotyping in pulmonary tuberculosis patients before and after treatment.

Barcelos W, Martins-Filho OA, Guimarães TM, Oliveira MH, Spíndola-de-Miranda S, Carvalho BN, Toledo Vde P.

Microbiol Immunol. 2006;50(8):597-605.

18.

Systemic Immunological changes in patients with distinct clinical outcomes during Mycobacterium tuberculosis infection.

Morais-Papini TF, Coelho-Dos-Reis JGA, Wendling APB, do Vale Antonelli LR, Wowk PF, Bonato VLD, Augusto VM, Elói-Santos S, Martins-Filho OA, Carneiro CM, Teixeira-Carvalho A.

Immunobiology. 2017 Nov;222(11):1014-1024. doi: 10.1016/j.imbio.2017.05.016. Epub 2017 May 26.

PMID:
28619539
19.

Differences in IgG responses against infection phase related Mycobacterium tuberculosis (Mtb) specific antigens in individuals exposed or not to Mtb correlate with control of TB infection and progression.

Coppola M, Arroyo L, van Meijgaarden KE, Franken KL, Geluk A, Barrera LF, Ottenhoff THM.

Tuberculosis (Edinb). 2017 Sep;106:25-32. doi: 10.1016/j.tube.2017.06.001. Epub 2017 Jun 8.

20.

Supplemental Content

Support Center